Trial intelligence / Profile preview

Fluconazole for prophylaxis of oral mucositis in head and neck cancer during concurrent chemoradiotherapy

TCTR20210326005Phase 3Completed

Sponsor
Chiang Mai University
Start
Jul 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fluconazole in head and neck cancer (HNC), stomatitis, sponsored by Chiang Mai University. Started Jul 2021; status: completed.

02

Drugs

fluconazole
03

Conditions

head and neck cancer (HNC)stomatitis

Beyond the preview

Go deeper on TCTR20210326005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210326005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call